Literature DB >> 17371240

Role of class II phosphoinositide 3-kinase in cell signalling.

M Falasca1, T Maffucci.   

Abstract

Although it is now well established that PI3K (phosphoinositide 3-kinase) is a key enzyme in several intracellular processes, there are still relatively few reports that precisely identify the specific isoforms of PI3K actually involved in such events. The lack of specific inhibitors has made it particularly difficult to address the physiological roles of some isoforms, such as the members of class II. As a consequence, there is still relatively little understanding of the role of these enzymes and the question about the intracellular role of these isoforms still waits for more answers.

Mesh:

Substances:

Year:  2007        PMID: 17371240     DOI: 10.1042/BST0350211

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  38 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 2.  Autophagosome formation in mammalian cells.

Authors:  Chloe Burman; Nicholas T Ktistakis
Journal:  Semin Immunopathol       Date:  2010-08-26       Impact factor: 9.623

3.  Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Authors:  Bizunesh Abere; Naira Samarina; Silvia Gramolelli; Jessica Rückert; Gisa Gerold; Andreas Pich; Thomas F Schulz
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Rapamycin and mTOR kinase inhibitors.

Authors:  Lisa M Ballou; Richard Z Lin
Journal:  J Chem Biol       Date:  2008-05-15

5.  Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.

Authors:  Kazuaki Yoshioka; Kotaro Yoshida; Hong Cui; Tomohiko Wakayama; Noriko Takuwa; Yasuo Okamoto; Wa Du; Xun Qi; Ken Asanuma; Kazushi Sugihara; Sho Aki; Hidekazu Miyazawa; Kuntal Biswas; Chisa Nagakura; Masaya Ueno; Shoichi Iseki; Robert J Schwartz; Hiroshi Okamoto; Takehiko Sasaki; Osamu Matsui; Masahide Asano; Ralf H Adams; Nobuyuki Takakura; Yoh Takuwa
Journal:  Nat Med       Date:  2012-09-16       Impact factor: 53.440

6.  Targeting PI3K in Cancer: Any Good News?

Authors:  Miriam Martini; Elisa Ciraolo; Federico Gulluni; Emilio Hirsch
Journal:  Front Oncol       Date:  2013-05-08       Impact factor: 6.244

7.  Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β.

Authors:  Xinjiang Cai; Shekhar Srivastava; Yi Sun; Zhai Li; Haiyan Wu; Ljiljana Zuvela-Jelaska; Jun Li; Rachel S Salamon; Jonathan M Backer; Edward Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-29       Impact factor: 11.205

Review 8.  PI3K signaling in Leishmania infections.

Authors:  Peter E Kima
Journal:  Cell Immunol       Date:  2016-09-07       Impact factor: 4.868

9.  Specificity of Collybistin-Phosphoinositide Interactions: IMPACT OF THE INDIVIDUAL PROTEIN DOMAINS.

Authors:  Michaela Ludolphs; Daniela Schneeberger; Tolga Soykan; Jonas Schäfer; Theofilos Papadopoulos; Nils Brose; Hermann Schindelin; Claudia Steinem
Journal:  J Biol Chem       Date:  2015-11-06       Impact factor: 5.157

10.  Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade.

Authors:  Jae Youl Cho; Jongsun Park
Journal:  Int J Mol Sci       Date:  2008-11-12       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.